5 hasil untuk "Li-Jun Bi"
Menampilkan 1–5 · 4,35 detik · RSS
-
Artikel Jurnal Teks lengkap
Identification and Separation of Transformed Products of tert-Butylhydroquinone Added in Different Oils and Fats during Storage
The transformation of tert-butylhydroquinone (TBHQ) added in lard, soybean and palm oil was investigated during storage. The results showed that when the storage time was extended, the sum of the remaining amount of TBHQ and the production of 2-tert-butyl-1,4-benzoquinone (TBBQ) in oil samples was…
-
Artikel Jurnal Teks lengkap
MSMEG_2731, an uncharacterized nucleic acid binding protein from Mycobacterium smegmatis, physically interacts with RPS1.
While the M. smegmatis genome has been sequenced, only a small portion of the genes have been characterized experimentally. Here, we purify and characterize MSMEG_2731, a conserved hypothetical alanine and arginine rich M. smegmatis protein. Using ultracentrifugation, we show that MSMEG_2731 is a…
-
Artikel Jurnal Teks lengkap
A Sir2-like protein participates in mycobacterial NHEJ.
In eukaryotic cells, repair of DNA double-strand breaks (DSBs) by the nonhomologous end-joining (NHEJ) pathway is critical for genome stability. In contrast to the complex eukaryotic repair system, bacterial NHEJ apparatus consists of only two proteins, Ku and a multifunctional DNA ligase (LigD)…
-
Artikel Jurnal Teks lengkap
Detection of B. anthracis spores and vegetative cells with the same monoclonal antibodies.
Bacillus anthracis, the causative agent of anthrax disease, could be used as a biothreat reagent. It is vital to develop a rapid, convenient method to detect B. anthracis. In the current study, three high affinity and specificity monoclonal antibodies (mAbs, designated 8G3, 10C6 and 12F6) have been…
-
Artikel Jurnal Teks lengkap
Preliminary study on efficacy and safety of fluzoparib in patients with metastatic castration-resistant prostate cancer
Background and purpose: Inhibitors of poly (ADP-ribose) polymerase (PARPi) has been shown in multiple clinical trials to benefit survival in patients with homologous recombination repair (HRR) gene mutations in metastatic castration-resistant prostate cancer (mCRPC). Fluzoparib has been approved…